These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

623 related articles for article (PubMed ID: 36314770)

  • 21. NAD
    Hou Y; Wei Y; Lautrup S; Yang B; Wang Y; Cordonnier S; Mattson MP; Croteau DL; Bohr VA
    Proc Natl Acad Sci U S A; 2021 Sep; 118(37):. PubMed ID: 34497121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycolytic preconditioning in astrocytes mitigates trauma-induced neurodegeneration.
    Solano Fonseca R; Metang P; Egge N; Liu Y; Zuurbier KR; Sivaprakasam K; Shirazi S; Chuah A; Arneaud SL; Konopka G; Qian D; Douglas PM
    Elife; 2021 Sep; 10():. PubMed ID: 34473622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The STING pathway does not contribute to behavioural or mitochondrial phenotypes in Drosophila Pink1/parkin or mtDNA mutator models.
    Lee JJ; Andreazza S; Whitworth AJ
    Sci Rep; 2020 Feb; 10(1):2693. PubMed ID: 32060339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repulsive Guidance Molecule a (RGMa) Induces Neuropathological and Behavioral Changes That Closely Resemble Parkinson's Disease.
    Korecka JA; Moloney EB; Eggers R; Hobo B; Scheffer S; Ras-Verloop N; Pasterkamp RJ; Swaab DF; Smit AB; van Kesteren RE; Bossers K; Verhaagen J
    J Neurosci; 2017 Sep; 37(39):9361-9379. PubMed ID: 28842419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microglia affect α-synuclein cell-to-cell transfer in a mouse model of Parkinson's disease.
    George S; Rey NL; Tyson T; Esquibel C; Meyerdirk L; Schulz E; Pierce S; Burmeister AR; Madaj Z; Steiner JA; Escobar Galvis ML; Brundin L; Brundin P
    Mol Neurodegener; 2019 Aug; 14(1):34. PubMed ID: 31419995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dysregulation of the Mitochondrial Unfolded Protein Response Induces Non-Apoptotic Dopaminergic Neurodegeneration in
    Martinez BA; Petersen DA; Gaeta AL; Stanley SP; Caldwell GA; Caldwell KA
    J Neurosci; 2017 Nov; 37(46):11085-11100. PubMed ID: 29030433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuronal DAMPs exacerbate neurodegeneration via astrocytic RIPK3 signaling.
    Chang NP; DaPrano EM; Lindman M; Estevez I; Chou TW; Evans WR; Nissenbaum M; McCourt M; Alzate D; Atkins C; Kusnecov AW; Huda R; Daniels BP
    JCI Insight; 2024 May; 9(11):. PubMed ID: 38713518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glial Nrf2 signaling mediates the neuroprotection exerted by
    Lin YE; Lin CH; Ho EP; Ke YC; Petridi S; Elliott CJ; Sheen LY; Chien CT
    Elife; 2021 Nov; 10():. PubMed ID: 34779396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nilotinib inhibits microglia-mediated neuroinflammation to protect against dopaminergic neuronal death in Parkinson's disease models.
    Wu J; Xu X; Zheng L; Mo J; Jin X; Bao Y
    Int Immunopharmacol; 2021 Oct; 99():108025. PubMed ID: 34364303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T cell infiltration and upregulation of MHCII in microglia leads to accelerated neuronal loss in an α-synuclein rat model of Parkinson's disease.
    Subbarayan MS; Hudson C; Moss LD; Nash KR; Bickford PC
    J Neuroinflammation; 2020 Aug; 17(1):242. PubMed ID: 32799878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroinflammation and Parkinson's Disease-From Neurodegeneration to Therapeutic Opportunities.
    Araújo B; Caridade-Silva R; Soares-Guedes C; Martins-Macedo J; Gomes ED; Monteiro S; Teixeira FG
    Cells; 2022 Sep; 11(18):. PubMed ID: 36139483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cx3cr1-deficiency exacerbates alpha-synuclein-A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease.
    Castro-Sánchez S; García-Yagüe ÁJ; López-Royo T; Casarejos M; Lanciego JL; Lastres-Becker I
    Glia; 2018 Aug; 66(8):1752-1762. PubMed ID: 29624735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration.
    Lee E; Hwang I; Park S; Hong S; Hwang B; Cho Y; Son J; Yu JW
    Cell Death Differ; 2019 Jan; 26(2):213-228. PubMed ID: 29786072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calpain activation and progression of inflammatory cycles in Parkinson's disease.
    Gao A; McCoy HM; Zaman V; Shields DC; Banik NL; Haque A
    Front Biosci (Landmark Ed); 2022 Jan; 27(1):20. PubMed ID: 35090325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lycopodium Attenuates Loss of Dopaminergic Neurons by Suppressing Oxidative Stress and Neuroinflammation in a Rat Model of Parkinson's Disease.
    Jayaraj RL; Beiram R; Azimullah S; Meeran MFN; Ojha SK; Adem A; Jalal FY
    Molecules; 2019 Jun; 24(11):. PubMed ID: 31185705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease.
    Gao HM; Zhang F; Zhou H; Kam W; Wilson B; Hong JS
    Environ Health Perspect; 2011 Jun; 119(6):807-14. PubMed ID: 21245015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease.
    Chen J; Mao K; Yu H; Wen Y; She H; Zhang H; Liu L; Li M; Li W; Zou F
    J Neuroinflammation; 2021 Dec; 18(1):295. PubMed ID: 34930303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroinflammation in Parkinson's disease: role in neurodegeneration and tissue repair.
    Vivekanantham S; Shah S; Dewji R; Dewji A; Khatri C; Ologunde R
    Int J Neurosci; 2015; 125(10):717-25. PubMed ID: 25364880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurodegeneration by α-synuclein-specific T cells in AAV-A53T-α-synuclein Parkinson's disease mice.
    Karikari AA; McFleder RL; Ribechini E; Blum R; Bruttel V; Knorr S; Gehmeyr M; Volkmann J; Brotchie JM; Ahsan F; Haack B; Monoranu CM; Keber U; Yeghiazaryan R; Pagenstecher A; Heckel T; Bischler T; Wischhusen J; Koprich JB; Lutz MB; Ip CW
    Brain Behav Immun; 2022 Mar; 101():194-210. PubMed ID: 35032575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD73-derived adenosine controls inflammation and neurodegeneration by modulating dopamine signalling.
    Meng F; Guo Z; Hu Y; Mai W; Zhang Z; Zhang B; Ge Q; Lou H; Guo F; Chen J; Duan S; Gao Z
    Brain; 2019 Mar; 142(3):700-718. PubMed ID: 30689733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.